Trade Summary

5 days ago, Khattar Jack A., serving as Pres, CEO at Supernus Pharmaceuticals, Inc. (SUPN), sold 35,000 shares at $50.38 per share, for a total transaction value of $1,763,124.00. Following this transaction, Khattar Jack A. now holds 2,199,244 shares of SUPN.

This sale represents a 2.00% decrease in Khattar Jack A.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, March 13, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 16, 2026, 3 days after the trade was made.

Supernus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.